Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
CTMedic's Profile
Displaying 901-950 of 1653 result(s).
CYDY CytoDyn Inc
10/24/2020 6:10:51 PM
Aspirin likely better than remdesiv (3)
CYDY CytoDyn Inc
10/23/2020 7:41:33 AM
Ohm20, Trial results can be taken e (1)
CYDY CytoDyn Inc
10/22/2020 11:26:47 PM
Rubraquercus, Cash for ongoing oper (3)
CYDY CytoDyn Inc
10/22/2020 10:16:35 PM
smurph, I'm not sure he really mean
CYDY CytoDyn Inc
10/22/2020 8:08:20 PM
nbmr1, I think there are politics i (3)
CYDY CytoDyn Inc
10/22/2020 7:45:01 PM
It is profoundly disappointing to s (5)
CYDY CytoDyn Inc
10/22/2020 4:13:16 PM
Index, Itolizumab given EUA based o (4)
CYDY CytoDyn Inc
10/22/2020 4:08:28 PM
Ritz, The chart fellow I follow mos (7)
CYDY CytoDyn Inc
10/22/2020 9:34:47 AM
Ken, I do my best with old eyes and (2)
CYDY CytoDyn Inc
10/22/2020 9:08:50 AM
SeeWhy, Amazing that L&S is largest (3)
CYDY CytoDyn Inc
10/22/2020 6:56:20 AM
Good to go, CD12 inclusion criteria
CYDY CytoDyn Inc
10/21/2020 7:41:09 PM
HCIT, Hopefully a vaccine helps mit (2)
CYDY CytoDyn Inc
10/21/2020 10:32:29 AM
Dr. Frank, I apologize for not appr (4)
CYDY CytoDyn Inc
10/21/2020 10:04:42 AM
Dr. Frank, The DSMC recommendation (18)
CYDY CytoDyn Inc
10/21/2020 9:10:52 AM
Laundry, I voted for the equity inc (5)
CYDY CytoDyn Inc
10/21/2020 9:01:01 AM
Nickie, You asked why Why wasn't so (1)
CYDY CytoDyn Inc
10/21/2020 8:34:38 AM
Nickie, SAF already laughed, but di (3)
CYDY CytoDyn Inc
10/21/2020 7:50:19 AM
Enrollment in CD12 may be more robu (2)
CYDY CytoDyn Inc
10/20/2020 5:52:54 PM
Crazy, I believe they have the lero (3)
CYDY CytoDyn Inc
10/20/2020 4:15:20 PM
Captn, No need for a phase 4 if ler (1)
CYDY CytoDyn Inc
10/20/2020 3:40:41 PM
Indexguy, Projections are optimisti (1)
CYDY CytoDyn Inc
10/20/2020 3:34:00 PM
CapnAmerica, We are all frustrated. (2)
CYDY CytoDyn Inc
10/20/2020 3:20:33 PM
CDiddy, You're observation is spot (4)
CYDY CytoDyn Inc
10/20/2020 2:57:12 PM
Captn, There is no mechanism to get (2)
CYDY CytoDyn Inc
10/20/2020 11:48:38 AM
Lee, Leronlimab trialing at 15 site (3)
CYDY CytoDyn Inc
10/20/2020 11:46:51 AM
Someone should tell Rush Limbaugh a (4)
CYDY CytoDyn Inc
10/20/2020 11:23:46 AM
Gilead under 60, 52 week low. It ap (2)
CYDY CytoDyn Inc
10/20/2020 10:05:24 AM
CDIddy, I'm perplexed by your state (4)
CYDY CytoDyn Inc
10/20/2020 7:50:46 AM
SAF, I believe you are 100% correct (6)
CYDY CytoDyn Inc
10/19/2020 12:48:22 PM
Calstang, Great post and reminder o (1)
CYDY CytoDyn Inc
10/19/2020 6:28:26 AM
Calstang, I am not aware of additio (2)
CYDY CytoDyn Inc
10/18/2020 6:05:17 PM
Smurph, I don’t believe there is
CYDY CytoDyn Inc
10/18/2020 3:54:19 PM
Smurph, It depends which portion of
CYDY CytoDyn Inc
10/18/2020 3:20:52 PM
blafarm, themediaframe is just a st (2)
CYDY CytoDyn Inc
10/18/2020 2:44:57 PM
Blafarm, I have not kept abreast of
CYDY CytoDyn Inc
10/18/2020 2:37:55 PM
SAF, I certainly don’t have any g (2)
CYDY CytoDyn Inc
10/18/2020 12:49:00 PM
SAF, If numbers are there and FDA b (3)
CYDY CytoDyn Inc
10/18/2020 10:57:22 AM
Great graphic demonstrating CCR5 si (1)
CYDY CytoDyn Inc
10/18/2020 6:28:15 AM
I have seen no indication they are
CYDY CytoDyn Inc
10/16/2020 5:32:47 PM
I apologize for over reacting. Welc (1)
CYDY CytoDyn Inc
10/16/2020 3:58:35 PM
Jamming, What matters are clinical (2)
CYDY CytoDyn Inc
10/16/2020 3:56:03 PM
We’re that the case (30 LL deaths (2)
CYDY CytoDyn Inc
10/16/2020 3:52:06 PM
Boy this smells of manipulation. Fi (7)
CYDY CytoDyn Inc
10/16/2020 4:03:38 AM
.... or roll with the punches and k (2)
CYDY CytoDyn Inc
10/16/2020 12:39:01 AM
FBCoach, I stole this post from Who (5)
CYDY CytoDyn Inc
10/16/2020 12:30:36 AM
ohm20, My assumption is that the FD (3)
CYDY CytoDyn Inc
10/16/2020 12:02:23 AM
Ohm20, The FDA guidance for clinica
CYDY CytoDyn Inc
10/15/2020 11:59:40 PM
nbmr1, You're right on all counts ( (3)
CYDY CytoDyn Inc
10/15/2020 11:43:08 PM
nmbr1, I am curious what the messag (1)
CYDY CytoDyn Inc
10/15/2020 11:39:20 PM
nbmr1, Each to his own. I choose to
Go to page:
  • << First
  • < Previous
  • 18
  • 19
  • Next >

Recent Articles

  • SALOMON Launches Unique Concept Store to Boost Retail in China
  • Tesla Launches Robotaxi Service in Texas, Competing with Uber
  • RoboSense Unveils Groundbreaking Active Camera at Robotics Event
  • Tegna's Stock Surges Amid Nexstar Acquisition Talks
  • India's Shift in Defense Strategy: Delays and Implications
  • Design a Workshop That Stays Safe, Efficient, and Flexible
  • Apple's Leadership Challenge in AI: A Crucial Turning Point
  • Texas Attorney General's Battle Against Democratic Defiance
  • Folqs Launches First-Day Colostrum Powder to Meet Rising Demand
  • AONMeetings Introduces Affordable Webinar Solutions for All
  • Neogen Corporation Investors Alert: Class Action Update Received
  • Investor Update: Hims & Hers Issues Legal Notice for Shareholders
  • Sable Offshore Investors: Act Now to Protect Your Rights
  • Investors Urged to Act: Flywire Corporation Class Action Update
  • Nvidia's H20 Chip Exports to China: A Pivotal Opportunity
  • Discover the Legacy of Savoy with Engaging Lecture Series
  • Upcoming Trump-Putin Summit in Alaska Sparks Market Activity
  • Elegoo Introduces Innovative Creator Fund to Support 3D Design
  • Elegoo Unveils Groundbreaking Creator Fund for Innovators
  • America's Progress Under President Trump's Leadership Explored
  • Legal Proceedings Update for Sarepta Therapeutics Investors
  • America's Bright Future: A Look at Trump's Recent Achievements
  • Uncovering the Lawsuit against Sable Offshore Corp: SOC Investors
  • Anbio Biotechnology Innovates Rapid Testing for Outbreaks
  • Exploring the Heritage of the Savoy Lecture Series Events
  • Columbia University Faces Legal Action After Major Data Breach
  • Understanding Your Rights in Altimmune, Inc. Class Action
  • Investors Invited to Join Capricor Therapeutics Class Action
  • Anbio Biotechnology Innovates with Rapid Testing and PCR Systems
  • The Dynamics of Semiconductor Growth Amidst Global Competition
  • Financial Highlights of First National Bank Alaska's Q2 2025
  • Questerre Energy Corporation Achieves Significant Growth in Q2
  • Strong Second Quarter Results for First National Bank Alaska
  • Questerre Energy Corporation's Impressive Q2 2025 Performance
  • Easterly ROCMuni Fund Investors Can Join Ongoing Legal Action
  • Q-Gold Resources Expands Horizons with Strategic Updates
  • Blade Air Mobility: Shaping the Future of Air Transport
  • Investors Invited to Join CTO Realty Growth Class Action Lawsuit
  • Blade Air Mobility Set to Make Waves at Upcoming Conference
  • Thumzup Media Unveils Public Offering for Preferred Stock Expansion
  • Q-Gold Resources Progresses with Quartz Mountain Project Update
  • XORTX Therapeutics Raises USD $114,500 Through Private Placement
  • Intermap Technologies Set to Share Q2 Earnings Updates Soon
  • XORTX Therapeutics Raises Funds Through Private Placement
  • The Remarkable Growth of Sterling Infrastructure Stock Over 15 Years
  • Intermap Technologies Sharing Insights on Upcoming Earnings Event
  • Introducing AutoSave: Your Smart Choice for Energy Savings
  • Ardagh Group Secures Major Support for Transaction Agreement
  • Wisconsin Enhances APRN Autonomy with New Legislation
  • Crown Capital Partners Reports Q2 2025 Financial Performance
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site